Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 1,179,816 | |
| Tax withholding / forfeiture | 2 | 6,163 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
36 Form 4 filings on record, the earliest from Nov 4, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock | 6,939 | $0.00 | - | ||
| Grant or award | Common Stock | 24,898 | $0.00 | - | ||
| Keith Bradley - Director | Tax withholding / forfeiture | Common Stock | 392 | $12.25 | $5K | |
| Keith Bradley - Director | Grant or award | Common Stock | 19,592 | $0.00 | - | |
| Jeffrey A. Graves - Director | Grant or award | Common Stock | 19,592 | $0.00 | - | |
| Open-market sale | Common Stock | 4,070 | $24.60 | $100K | ||
| Michael J. McBreen - Officer | Open-market sale | Common Stock | 1,700 | $24.16 | $41K | |
| Witte Jan de - Officer | Option exercise | Common Stock | 9,814 | $0.00 | - | |
| Witte Jan de - Officer | Tax withholding / forfeiture | Common Stock | 4,262 | $19.28 | $82K | |
| Witte Jan de - Officer | Option exercise | Restricted Stock Units | 9,814 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 36 IART filings on record.
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had 6 insider filings in the last 90 days, with the most recent on 2026-07-06. The full record for IART runs to 36 Form 4 filings, the earliest from 2024-11-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IART were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of IART were filed in the last 90 days. 2 sales are on record for this company.
This page tracks IART Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IART to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.